We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| LeMaitre Vascular Inc | NASDAQ:LMAT | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 75.90 | 62.00 | 79.83 | 0 | 09:05:07 |
From May 2019 to May 2024
JJ Pellegrino, Chief Financial Officer, is scheduled to present at the Canaccord Medical Technologies & Diagnostics Forum on Thursday, November 9, 2017 at the Westin Grand Central Hotel in New York City. The Company’s presentation is scheduled to begin at 11:30 AM EST.
David Roberts, President, is scheduled to present at the Stifel 2017 Healthcare Conference on Tuesday, November 14, 2017 at the Lotte New York Palace Hotel in New York City. The Company’s presentation is scheduled to begin at 2:45 PM EST.
Steven Chehames, Investor Relations, is scheduled to present at the Three Part Advisors Southwest IDEAS Conference on Thursday, November 16, 2017 at the Westin Dallas Hotel in Dallas. The Company’s presentation is scheduled to begin at 8:40 AM CST.
George LeMaitre, Chairman & CEO, will participate in the Craig-Hallum Alpha Select Conference on Thursday, November 16, 2017 at the Sheraton New York Times Square Hotel in New York City.
David Roberts, President, is scheduled to present at the Piper Jaffray Healthcare Conference on Tuesday, November 28, 2017 at the Lotte New York Palace Hotel in New York City. The Company’s presentation is scheduled to begin at 11:10 AM EST.
David Roberts, President, will participate in the Guggenheim Annual Boston Healthcare Conference on Wednesday, December 13, 2017 at the InterContinental Hotel in Boston.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
Contact: LeMaitre Vascular, Inc.Investor Relations Steven Chehames+1-781-425-1659schehames@lemaitre.com
1 Year LeMaitre Vascular Chart |
1 Month LeMaitre Vascular Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
